PATENT CLAIM ANALYSIS

Application Number: 16001322
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure relates to methods of transitioning patients or obese patients being treated with vortioxetine to treatment with a monoamine oxidase inhibitor (MAOI). The methods provided include delaying administration of the MAOI for certain time periods after stopping administration of vortioxetine. The patients or obese patients possess various capabilities of metabolizing vortioxetine. The current disclosure also includes methods of switching patients to a MAOI intended to treat psychiatric disorders while being treated with vortioxetine. The methods disclosed further comprise determining vortioxetine plasma clearance and washout time for patients with different body fat status and/or different CYP2D6 metabolizer status.

Claim (Index 15):
The method of  claim 1 , wherein the patient is a poor CYP2D6 metabolizer.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 94.0
- Lexical Diversity: 1.68254
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15838944', '15596585', '14034727', '11576178', '15636238']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7188254943556575
- 35 USC 102 Novelty (BERT): 0.6085706176054111
- Combined Prediction Score: 0.7078000066806328
- Mean Citation Score: 267.782782
- Max Citation Score: 560.754
- Similarity Product: 445.7224983626604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test